Loading search results
INTHEMO
INTHEMO: Occupational Integration of Adults With Severe Haemophilia in France: a Study Based on the FranceCoag Cohort
Sponsor study identifier
observational
590
1 country
1
Study Start
August 28, 2018
Actual (reported)Primary Completion
May 27, 2020
Actual (reported)Study Completion
May 27, 2020
Actual (reported)Severe haemophilia and subsequent arthropathy result in joint pain, disability and impaired health-related quality of life. Improvements in haemophilia care over the last decades might lead to expectation of a near-normal quality of life for adults with haemophilia. However, little is known about the impact of haemophilia and its treatment on social functioning. A study based on a national US cohort of 141 young men (18-34 y.o.) showed that, compared to the general US population, this cohort experienced social burdens such as unemployment and lower high-school graduation rates. Another study conducted in the framework of the HERO (Haemophilia Experiences, Results and Opportunities) international initiative showed that a majority of the 230 young adults aged 18-30 years (including 16 French participants) were employed at least part-time (62%) and most of them reported that haemophilia has had a negative impact on employment (76%) which was reported as moderate or very large by 47% of the participants. The replicability of these results could be limited by the specific socio-economic national context. In France, a survey was conducted in 2008 to assess quality of life and its determinants in children, adolescents and adults with moderate and severe haemophilia. Descriptive results on the socio-economic characteristics of the included adults showed that 51.3% of them had access to higher education (which was higher than the observed rate in the French general population in 2005, i.e. 32.5%), and that 52.1% were employed among whom 44.3% had an at-risk activity. In spite of these results which were presented in a descriptive report by the InVS (Institut de veille sanitaire - French Institute for Public Health Surveillance), some limitations could be discussed:
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
May 27, 2020
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 29, 2017
Actual (reported)October 4, 2017
Actual (reported)August 28, 2018
Actual (reported)May 27, 2020
Actual (reported)May 27, 2020
Actual (reported)Degree of employment
unemployment / part-time employment / full-time employment
one day
Access to higher education and high-school graduation
one day
Age at the start of working life
one day
Sheltered employment
one day
Job security
one day
adults with severe haemophilia
Hôpital de la Timone Assistance Publique Hôpitaux de Marseille
Marseille, 13354, France
Urielle DESALBRES
Assistance Publique Hôpitaux de Marseille
590 participants (actual enrollment reported by the registry).
First Submitted
September 29, 2017
First Posted
October 4, 2017
Study Start
August 28, 2018
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
May 27, 2020
Actual (reported)Study Completion
May 27, 2020
Actual (reported)Last Updated
February 15, 2023
Record last verified: 2023-02
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: